Loading organizations...
Key people at Pacific 8 Ventures.
Pacific 8 Ventures is a venture capital firm specializing in seed-stage investments within healthcare technology. It targets disruptive platforms intersecting biology and medicine, aiming to transform therapeutics, diagnostics, and health services. The firm often acts as the first institutional investor for innovative ventures leveraging advanced solutions for life science needs.
Founded in 2014, Pacific 8 Ventures was co-established by Chris Shu, Jack Liang, and Ser-Chen Fu, MD. Their insight centered on backing early-stage companies applying advanced technologies to complex biology and medicine challenges. This approach leveraged their deep expertise in venture capital and technology.
The firm empowers early-stage technology companies to scale impactful healthcare solutions, selected for their capacity to improve medical care. Pacific 8 Ventures envisions cultivating ventures that achieve market success while enhancing patient outcomes and reshaping the healthcare landscape through technological innovation.
Pacific 8 Ventures has 4 tracked investments across 3 companies. The latest tracked deal is $3.0M Seed in Interface Biosciences in December 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 6, 2023 | Interface Biosciences | $3.0M Seed | Gaingels, Sergey Jakimov, Seedfolio | Boom Capital, Pear VC, ULU Ventures |
| Sep 1, 2021 | Fauna Bio | $9.0M Seed | LifeForce Capital | Bija Ventures, Arcadia Science, Biomed Ventures, Boom Capital, True Ventures, Vibe Capital |
| Jan 1, 2020 | Mammoth Biosciences | $45.0M Series B | Decheng Capital | Khosla Ventures, KittyHawk Ventures, Kleiner Perkins, Plum Alley Investments, Esther Dyson, Gary Lauder, Brook Byers, Ursheet Parikh, NFX, Andrew Harrison |
| Apr 11, 2019 | Fauna Bio | $4.1M Seed | Rohit Sharma | Beagle Ventures, Boom Capital, Longevity Fund |
Key people at Pacific 8 Ventures.
